Safety and efficacy of doxycycline in the treatment of rosacea

References

• BergMLidenSAn epidemiological study of rosaceaActa Derm Venerol1989694194232572109
   PubMed Web of Science ®Google Scholar
• PowellFCRosaceaN Engl J Med200535279380315728812
   PubMed Web of Science ®Google Scholar
• WilkinJDahlMDetmarMStandard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of RosaceaJ Am Acad Dermatol20024658458711907512
   PubMed Web of Science ®Google Scholar
• PelleMTCrawfordGHJamesWDRosacea: II. TherapyJ Am Acad Dermatol20045149951215389184
   PubMed Web of Science ®Google Scholar
• SneddonIBA clinical trial of tetracycline in rosaceaBr J Dermatol1966786496524224811
   PubMed Web of Science ®Google Scholar
• SmilackJDThe tetracyclinesMayo Clin Proc19997472772910405705
   PubMed Web of Science ®Google Scholar
• SapadinANFleischmajerRTetracyclines: Nonantibiotic properties and their clinical implicationsJ Am Acad Dermatol200654225826516443056
   PubMed Web of Science ®Google Scholar
• MaibachHSecond-generation tetracyclines, a dermatologic overview: Clinical uses and pharmacologyCutis1991484114171764965
   PubMed Web of Science ®Google Scholar
• CunhaBASibleyCMRistucciaAMReview doxycyclineTher Drug Monit198241151357048645
   PubMed Web of Science ®Google Scholar
• JonasMCunhaBAReview minocyclineTher Drug Monit198241371457048646
   PubMed Web of Science ®Google Scholar
• MacdonaldHKellyRGAllenESPharmacokinetic studies of minocycline in manClin Pharmacol Ther1973148524199710
   PubMed Web of Science ®Google Scholar
• SaivinSHouinGClinical pharmacokinetics of doxycycline and minocyclineClinical Pharmacokinet198815355366
   PubMed Web of Science ®Google Scholar
• FabreJMilekEKalfopoulosPThe kinetics of tetracyclines in man. Digestive absorption and serum concentrationsSchweiz Med Wochenschr19711015935984995974
   PubMedGoogle Scholar
• WeinbergJMThe anti-inflammatory effects of tetracyclinesCutis200575 Suppl 4S6S11
   PubMed Web of Science ®Google Scholar
• CullenSCrounseRCutaneous pharmacology of the tetracyclinesJ Invest Dermatol1965452632684953785
   PubMed Web of Science ®Google Scholar
• PallettAPSmythEGClinician’s guide to antibiotics. TetracyclineBr J Hosp Med1988403853903069173
   PubMed Web of Science ®Google Scholar
• WebsterGDel RossoJQAntiinflammatory effects of TetracyclinesDermatology Clin200725133135
   PubMed Web of Science ®Google Scholar
• EsterlyNBFureyNLFlannaganLEThe effect of antimicrobial agents on chemotaxisJ Invest Dermatol1978705155618981
   PubMed Web of Science ®Google Scholar
• EsterlyNBKovanskyJSFureyNSNeutrophil chemotaxis in patients with acne receiving tetracyclinesArch Dermatol1984120130813136237616
   PubMedGoogle Scholar
• GablerWLCreamerHRSupression of human neutrophil functions by tetracyclineJ Periodontal Res19912652581847418
   PubMed Web of Science ®Google Scholar
• ThongYHFerranteAInhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogsClin Exp Immunol197935443446455782
   PubMed Web of Science ®Google Scholar
• PruzanskiWGreenwaldRAStreetIPLaliberteFStefanskiEVadasPInhibition of enzymatic activity of phospholipase A2 by minocycline and doxycyclineBiochem Pharmacol1992P44116511701417938
   PubMed Web of Science ®Google Scholar
• WiseRDSubmicrobial doxycycline and rosaceaComp Ther2007337881
   PubMedGoogle Scholar
• BikowskiJBSubantimicrobial dose doxycycline for acne and rosaceaSkinmed2003223424514673277
   PubMedGoogle Scholar
• GolubLMLeeHMRyanMEGiannobileWVPayneJSorsaTTetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanismsAdv Dent Res19981212269972117
   PubMedGoogle Scholar
• GolubLMLeeHMLehrerGMinocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of actionJ Periodont Res1983185165266315909
   PubMed Web of Science ®Google Scholar
• GolubLMRamamurthyNSMcNamaraTFGreenwaldRARifkinBRTetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugsCrit Rev Oral Biol Med199122973211654139
   PubMedGoogle Scholar
• BermanBZellDSubantimicrobial dose doxycycline: a unique treatment for rosaceaCutis200575 Suppl 4S19S24
   Web of Science ®Google Scholar
• BikowskiJNew approaches to rosacea therapySkin Aging200513 Suppl 2S13S15
   Google Scholar
• HanemaaijerRVisserHKoolwijkPInhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cellsAdv Dent Res1998121141189972133
   PubMedGoogle Scholar
• Del RossoJQWebsterGFJacksonMTwo randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosaceaJ Am Acad Dermatol20075679180217367893
   PubMed Web of Science ®Google Scholar
• WebsterGFTosoSMHegemannLInhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase CArch Dermatol19941307487528002645
   PubMedGoogle Scholar
• AminARAtturMGThakkerGDA novel mechanism of action of tetracyclines: effects on nitric oxide synthasesProc Natl Acad of Sci U S A19969314014140198943052
   PubMed Web of Science ®Google Scholar
• AminARPatelRNThakkerGDLowensteinCJAtturMGAbramsonSBPost-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclinesFEBS Lett19974102592649237641
   PubMed Web of Science ®Google Scholar
• SkidmoreRKovachRWalkerCEffects of subantimicrobial-dose doxycycline in the treatment of moderate acneArch Dermatol2003139 445946412707093
   PubMed Web of Science ®Google Scholar
• ThiboutotDEfficacy and safety of subantmicrobial-dose doxycycline for the treatment of rosacea [poster]63rd Annual Meeting of the American Academy of DermatologyFebruary 18–22, 2005New Orleans, LAP128
   Google Scholar
• SanchezJSomolinosALAlmodovarPIWebsterGBradshawMPowalaCA randomized, double-blinded, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosaceaJ Am Acad Dermatol20055379179716243127
   PubMed Web of Science ®Google Scholar
• FowlerJFCombined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, USP monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosaceaJ Drugs Dermatol2007664164517668530
   PubMedGoogle Scholar
• Del RossoJSchlessingerJWerschlerPComparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosaceaJ Drugs Dermatol2008757357618561589
   PubMed Web of Science ®Google Scholar
• AkpekEKMerchantAPinarVFosterCSOcular rosacea: Patient characteristics and follow-upOphthalmology1997104186318679373118
   PubMed Web of Science ®Google Scholar
• Frucht-PeryJChayetASFelmanSTLinSBrownSIThe effect of doxycycline in ocular rosaceaAm J Ophthalmol19891074344352522739
   PubMed Web of Science ®Google Scholar
• Frucht-PeryJSagiEHemoIEver-HadaniPEfficacy of doxycycline and tetracycline in ocular rosaceaAm J Ophthalmol199311688928328549
   PubMed Web of Science ®Google Scholar
• QuatermanMJJohnsonDWAbeleDCLesherJLHullDSDavisLSOcular rosacea: Signs, symptoms, and tear studies before and after treatment with doxycyclineArch Dermatol199713349549006372
   PubMedGoogle Scholar
• TorresaniCPavesiAManaraGCClarithromycin versus doxycycline in the treatment of rosáceaInt J Dermatol1997369389469466205
   PubMed Web of Science ®Google Scholar
• AkhyaniMEhsaniAHGhiasiMJafariAKComparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trialInt J Dermatol20084728428818289334
   PubMed Web of Science ®Google Scholar
• HersleKGisslenHMinocycline in acne vulgaris: a double-blind studyCurr Ther Res197619339342131678
   PubMed Web of Science ®Google Scholar
• HarrisonPVA comparison of doxycycline and minocycline in the treatment of acne vulgarisClin Exp Dermatol1988132422442977578
   PubMed Web of Science ®Google Scholar
• LauxBTreatment of acne vulgaris. A comparison of doxycycline versus minocyclineDermatologist198940577581
   Google Scholar
• OlafssonJHGudgiersonJEggertsdottirGEKristjanssonFDoxycycline versus minocycline in the treatment of acne vulgaris: a doubleblind studyJ Dermatol Treat198911517
   Google Scholar
• Del RossoJQRecently approved systemic therapies for acne vulgaris and rosaceaCutis20078011312017944168
   PubMed Web of Science ®Google Scholar
• EadyAHCoveJHLaytonAMIs antibiotic resitance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribersAm J Clin Dermatol2003481383114640775
   PubMed Web of Science ®Google Scholar
• ThomasJWalkerCBradshawMLong-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibilityJ Perio20007114721483
   PubMed Web of Science ®Google Scholar
• GolubLMSorsaTLeeHMDoxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingivaJ Clin Periodontol1995221001097775665
   PubMed Web of Science ®Google Scholar
• Del RossoJQA status report on the use of subantimicrobial-dose doxycycline: A review of the biologic and antimicrobial effects of the tetracyclinesCutis20047411812215379364
   PubMed Web of Science ®Google Scholar
• WalkerCWebsterGFDel RossoJQA muticenter, double-blind, randomized trial to evaluate the long-term anti-inflammatory doxycycline (40 mg) therapy: results of the lack of effect on bacterial flora [poster]Foundation for Reaserch and Education in Dermatology, Fall Clinical Dermatology ConferenceOctober 6–9, 2006Las Vegas, Nevada
   Google Scholar
• SloanBScheinfeldNThe use and safety of doxycycline hyclate and other second-generation tetracyclinesExpert Opin Drug Saf2008757157718759709
   PubMed Web of Science ®Google Scholar
• Del RossoJQSystemic therapy for rosacea: focus on oral antibiotic therapy and safetyCutis20006671311455753
   PubMedGoogle Scholar
• ShapiroLEKnowlesSRShearNHComparative safety of tetracycline, minocycline, and doxycyclineArch Dermatol1997133122412309382560
   PubMed Web of Science ®Google Scholar
• SmithKLeydenJJSafety of doxycycline and mnocycline: a systematic reviewClin Ther2005271329134216291409
   PubMed Web of Science ®Google Scholar
• SegelnickSLWeinbergMARecognizing doxycycline-induced esophageal ulcers in dental practice: a case report and reviewJ Am Dent Assoc200813958158518451374
   PubMed Web of Science ®Google Scholar
• BillerJAFloresABuieTMazorSKatzAJTetracycline-induced esophagitis in adolescent patientsJ Pediatr19921201441451731012
   PubMed Web of Science ®Google Scholar
• SmilackJDThe tetracyclinesMayo Clin Proc19997472772910405705
   PubMed Web of Science ®Google Scholar
• LanzaFLEsophageal ulceration produced by doxycycline Review of the literature and comparison of the injury from doxycycline hyclate and hydrochloride with that from doxycycline monohydrateCurr Ther Res Clin Exp198844475484
   Web of Science ®Google Scholar
• BergerRSA double-blind, multiple-dose, placebo-controlled, cross-over study to compare the incidence of gastrointestinal complaints in healthy subjects given Doryx R and Vibramycin RJ Clin Pharmacol1988283673703392234
   PubMed Web of Science ®Google Scholar
• SmithKLeydenJJSafety of doxycycline and minocycline: a systematic reviewClin Ther2005271329134216291409
   PubMed Web of Science ®Google Scholar
• CarrollLALaumannAEDoxycycline-induced photo-onycholysisJ Drugs Dermatol2003266266314711147
   PubMedGoogle Scholar
• LaytonAMCunliffeWJPhototoxic eruptions due to doxycycline-a dose-related phenomenonClin Exp Dermatol1993184254278252763
   PubMed Web of Science ®Google Scholar
• SimpsonMBPryzbylikJInnisBDenhamMAHemolytic anemia after tetracycline therapyN Engl J Med19853128408423974663
   PubMed Web of Science ®Google Scholar
• PierogSHAl-SalihiFLCinottiDPseudotumor cerebri – a complication of tetracycline treatment of acneJ Adolesc Health Care198671391402937759
   PubMedGoogle Scholar
• NelsonRParkerSRDoxycycline-induced staining of adult teeth: the first reported caseArch Dermatol20061421081108216924074
   PubMed Web of Science ®Google Scholar
• CacNNMessinghamMJSniezekPJWallingHWStevens-Johnson syndrome induced by doxycyclineCutis20077911912217388211
   PubMed Web of Science ®Google Scholar
• CurleyRKVerbowJLStevens-Johnson syndrome due to tetracycline-a case report (doxycycline) and a review of the literatureClin Exp Dermatol1987121241253677470
   PubMed Web of Science ®Google Scholar
• GallaisVRandrianjohannyARobineauMLarocheLStevens-Johnson syndrome caused by doxycyclinePresse Med1997268559207884
   PubMed Web of Science ®Google Scholar
• RoblesDTLeonardJLComptonNSevere drug hypersensitivity reaction in a young woman treated with doxycyclineDermatology2008217232618332631
   PubMed Web of Science ®Google Scholar
• GulUGonulMSoyluSKayaIDoxycycline-induced fixed drug eruptionJ Dermatolog Treat20081912612718484432
   PubMed Web of Science ®Google Scholar
• TrüebRMBurgGAcute generalized exanthematous pustulosis due to doxycyclineDermatology199318675788435524
   PubMed Web of Science ®Google Scholar
• Khan DuraniBJappeUDrug-induced Sweet’s syndrome in acne caused by different tetracyclines: case report and review of the literatureBr J Dermatol200214755856212207601
   PubMed Web of Science ®Google Scholar
• BermanBPerezOAZellDUpdate on rosacea and anti-inflammatory-dose doxycyclineDrugs Today200743273417315050
   PubMed Web of Science ®Google Scholar
• HarrisonPVA comparison of doxycycline and minocycline in the treatment of acne vulgarisClin Exp Dermatol1988132422442977578
   PubMed Web of Science ®Google Scholar
• AllenJCMinocyclineAnn Intern Med197685482487788583
   PubMed Web of Science ®Google Scholar
• BaciewiczAMBalBSBleeding associated with doxycycline and warfarin treatmentArch Intern Med2001161123111343446
   PubMedGoogle Scholar
• CaracoYRubinowAEnhanced anticoagulant effect of coumarin derivatives induced by doxycycline coadministrationAnn Pharmacother199226108410861421670
   PubMed Web of Science ®Google Scholar
• HasanSAInteraction of doxycycline and warfarin: an enhanced anti-coagulant effectCornea20072674274317592328
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFJKoerselmanJHeringsRMRisk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulantsJ Thromb Haemost2008628429018031295
   PubMed Web of Science ®Google Scholar
• BarrancoVPUpdate on clinically significant drug interactions in dermatologyJ Am Acad Dermatol20065467668416546592
   PubMed Web of Science ®Google Scholar
• DickinsonBDAltmanRDNielsenNHSterlingMLCouncil on Scientific Affairs, American Medical AssociationDrug interactions between oral contraceptives and antibioticsObstet Gynecol20019885386011704183
   PubMed Web of Science ®Google Scholar
• BackDJGrimmerSFOrmeMLProudloveCMannRDBreckenridgeAMEvaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anti-convulsants and antibioticsBr J Clin Pharmacol1988255275323408633
   PubMed Web of Science ®Google Scholar
• SzokaPREdgrenRADrug interactions with oral contraceptives: compilation and analysis of an adverse experience report databaseFertil Steril19884931S38S3282933
   PubMed Web of Science ®Google Scholar
• NeelyJLAbateMSwinkerMD’AngioRThe effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesteroneObstet Gynecol1991774164201992409
   PubMed Web of Science ®Google Scholar
• MurphyAAZacurHACharachePBurkmanRTThe effect of tetracycline on levels of oral contraceptivesAm J Obstet Gynecol199116428331986620
   PubMed Web of Science ®Google Scholar
• ArcherJSArcherDFOral contraceptive efficacy and antibiotic interaction: a myth debunkedJ Am Acad Dermatol20024691792312063491
   PubMed Web of Science ®Google Scholar
• FDA.gov (homepage on the Internet)Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) (updated 2009 Jan 23; cited 2009 Feb 26) Available from: http://www.fda.gov/cder/orange/default.htm
   Google Scholar